1. Home
  2. XOMA vs XPOF Comparison

XOMA vs XPOF Comparison

Compare XOMA & XPOF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XOMA
  • XPOF
  • Stock Information
  • Founded
  • XOMA 1981
  • XPOF 2017
  • Country
  • XOMA United States
  • XPOF United States
  • Employees
  • XOMA N/A
  • XPOF N/A
  • Industry
  • XOMA Biotechnology: Pharmaceutical Preparations
  • XPOF Services-Misc. Amusement & Recreation
  • Sector
  • XOMA Health Care
  • XPOF Consumer Discretionary
  • Exchange
  • XOMA Nasdaq
  • XPOF Nasdaq
  • Market Cap
  • XOMA 320.8M
  • XPOF 388.8M
  • IPO Year
  • XOMA N/A
  • XPOF 2021
  • Fundamental
  • Price
  • XOMA $28.59
  • XPOF $12.93
  • Analyst Decision
  • XOMA Strong Buy
  • XPOF Buy
  • Analyst Count
  • XOMA 2
  • XPOF 10
  • Target Price
  • XOMA $78.50
  • XPOF $16.85
  • AVG Volume (30 Days)
  • XOMA 18.9K
  • XPOF 248.5K
  • Earning Date
  • XOMA 11-05-2024
  • XPOF 11-05-2024
  • Dividend Yield
  • XOMA N/A
  • XPOF N/A
  • EPS Growth
  • XOMA N/A
  • XPOF N/A
  • EPS
  • XOMA N/A
  • XPOF N/A
  • Revenue
  • XOMA $15,239,000.00
  • XPOF $326,668,000.00
  • Revenue This Year
  • XOMA $456.45
  • XPOF $0.85
  • Revenue Next Year
  • XOMA $29.84
  • XPOF $9.33
  • P/E Ratio
  • XOMA N/A
  • XPOF N/A
  • Revenue Growth
  • XOMA 277.95
  • XPOF 15.41
  • 52 Week Low
  • XOMA $14.27
  • XPOF $7.40
  • 52 Week High
  • XOMA $30.50
  • XPOF $18.95
  • Technical
  • Relative Strength Index (RSI)
  • XOMA 53.55
  • XPOF 52.80
  • Support Level
  • XOMA $28.66
  • XPOF $11.35
  • Resistance Level
  • XOMA $30.50
  • XPOF $12.51
  • Average True Range (ATR)
  • XOMA 1.07
  • XPOF 0.46
  • MACD
  • XOMA 0.21
  • XPOF 0.10
  • Stochastic Oscillator
  • XOMA 55.56
  • XPOF 90.57

About XOMA XOMA Corporation

XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. When XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes.

About XPOF Xponential Fitness Inc.

Xponential Fitness Inc is a curator of boutique fitness brands. Its diversified portfolio of brands includes Club Pilates, a Pilates brand in the United States; CycleBar, an indoor cycling brand in the United States; StretchLab, a concept offering one-on-one and group stretching services; Row House, a high-energy, low-impact indoor rowing workout; AKT, a dance-based cardio workout combining toning, interval and circuit training; YogaSix, a franchised yoga brand; Pure Barre, a total body workout that uses the ballet barre to perform small isometric movements; Stride, a treadmill-based cardio and strength training concept; Rumble, a boxing-inspired full-body workout; and BFT, a functional training and strength-based program. Its key revenue source is franchise income.

Share on Social Networks: